Market Tracker

10/23 3:00pm ET

Biomarin Pharmaceutical Inc (NASDAQ:BMRN)

87.21
BATS BZX Real-Time Price
As of 3:00pm ET
 -0.54 / -0.62%
Today’s Change
78.42
Today|||52-Week Range
100.51
+5.28%
Year-to-Date

Today’s Trading

Previous close87.75
Today’s open88.04
Day’s range85.97 - 88.04
Volume38,451
Average volume (3 months)1,369,406
Market cap$15.4B
Dividend yield--
Data as of 3:00pm ET, 10/23/2017

Growth & Valuation

Earnings growth (last year)-256.07%
Earnings growth (this year)+80.39%
Earnings growth (next 5 years)+127.00%
Revenue growth (last year)+27.18%
P/E ratioNM
Price/Sales12.40
Price/Book5.48

Competitors

 Today’s
change
Today’s
% change
MYLMylan NV+0.12+0.31%
PRGOPerrigo Company PLC-0.70-0.80%
JAZZJazz Pharmaceuticals...-2.91-2.02%
ALNYAlnylam Pharmaceutic...+1.42+1.24%
Data as of 3:00pm ET, 10/23/2017

Financials

Next reporting dateOctober 26, 2017
EPS forecast (this quarter)-$0.11
Annual revenue (last year)$1.1B
Annual profit (last year)-$630.2M
Net profit margin-56.74%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman &
Chief Executive Officer
Jean-Jacques Bienaimé
Chief Financial Officer &
Executive Vice President
Dan Spiegelman
Corporate headquarters
San Rafael, California

Forecasts